European Society of Cardiology
111 articles about European Society of Cardiology
-
BG Medicine Release: Study Shows Galectin-3 Predicts Response to Statin Therapy in Chronic Heart Failure - Results Presented at European Society of Cardiology Congress 2011
8/29/2011
-
Data From Amarin Corporation PLC's AMR101 Phase 3 MARINE Trial to be Presented at the European Society of Cardiology Congress 2011
8/25/2011
-
BIOTRONIK Announces Compelling Program of Clinically and Scientifically Significant Presentations at European Society of Cardiology Congress 2011
8/25/2011
-
Bristol-Myers Squibb Company And Pfizer Inc. Announce Data Presentations for Apixaban at European Society of Cardiology Congress 2011
8/23/2011
-
BG Medicine to Host Webcast on Latest Results of Galectin-3 Studies From European Society of Cardiology Congress 2011
8/23/2011
-
Portola Pharmaceuticals, Inc. Announces Upcoming Oral Presentation of Factor Xa Inhibitor Antidote Data at European Society of Cardiology 2011 Congress
8/11/2011
-
BG Medicine New Studies on Role of Galectin-3 in Heart Failure to be Presented at European Society of Cardiology Congress 2011
8/2/2011
-
Cardiologists Want their Voices Heard in EU Medical-Device Regulatory-Reform Process, European Society of Cardiology Reveals
5/20/2011
-
CEO of ARCA biopharma to Present Gencaro Development Programs at the European Society of Cardiology’s Heart Failure Congress 2011
5/16/2011
-
Logic Product Development Medical Practice Director to Speak at European Society of Cardiology Boston
9/16/2010
-
Long Term Data Presented at European Society of Cardiology 2010 Shed Further Light on the Benefit of the CYPHER(R) Sirolimus Drug-Eluting Stent Compared to the ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
9/7/2010
-
European Society of Cardiology: In CABG, Two Grafts as Safe as One, John Radcliffe Hospital Study
9/3/2010
-
European Society of Cardiology: Pre-Procedure Statins May Cut MI Risk, University of Florida Study
9/2/2010
-
Cordis Corporation's Stent Does Better Than Medtronic, Inc.'s Stent in Study Presented at European Society of Cardiology 2010
9/2/2010
-
Cordis Corporation Release: Long Term Data Presented at European Society of Cardiology 2010 Shed Further Light on the Benefit of the CYPHER(R) Sirolimus Drug-Eluting Stent Compared to the ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgro
9/2/2010
-
Cardiogenesis Corporation Comments on the STAR-Heart Study Presented at European Society of Cardiology 2010 Congress
9/2/2010
-
St. Jude Medical Release: New 2010 European Society of Cardiology Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
9/1/2010
-
European Society of Cardiology: Novel Antiplatelet Heading in the Right Direction, Duke University Study
8/31/2010
-
European Society of Cardiology: New Guidelines Are a Step Ahead of Regulators, University of North Carolina Study
8/31/2010
-
TomTec Imaging Systems GmbH Introduces 4D MV-Assessment, the New 3D Solution for Improved Diagnostic Confidence in Mitral Valve Therapy at the TomTec Imaging Systems GmbH Congress in Stockholm
8/26/2010